$AFRM

Is Affirm Holdings, Inc. (AFRM) Stock a Buy After Goldman Sachs Raised Its Price Target?

Affirm Holdings (AFRM) saw its price target raised by Goldman Sachs to $115 from $106, citing strong Q4 results with revenue up 33% to $1.2B and operating income up $89M. The company's growth is driven by increased interest-bearing loans and the Affirm Card, with active cardholders doubling. However, risks include credit quality and competition in the BNPL space. Hedge fund holdings declined, and short interest is modest.

Original reporting
Published Sep 19, 2026, 8:08 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 19, 2026, 9:14 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Is Affirm Holdings, Inc. (AFRM) Stock a Buy After Goldman Sachs Raised Its Price Target? — source image
Decision brief

The 30-second read

$AFRMBullishMed
01

Why it matters

Earnings beat and analyst upgrade may trigger short covering and buying interest.

02

Market read

Affirm's earnings and upgraded targets provide a fresh catalyst for traders.

03

What to watch

Potential increase in loan delinquencies if consumer credit deteriorates.

Relevance 7/10Novelty 8/10Timing: post‑earnings release

Background

Affirm has been underperforming YTD but shows improving loan growth and a new partnership with Shopify in Australia.

Company-level read

Ticker impact

$AFRMBullishHigh confidence
Context

Affirm reported Q4 FY2026 revenue of $1.2B and operating income of $147M, and Goldman Sachs raised its price target to $115.

Expected impact

Potential upside of 5‑10% in the near term.

Evidence & confidence

Earnings beat and higher target provide a clear catalyst for buying pressure.

Market effects

Positive for the broader BNPL and fintech sector.

U.S. fintech stocks may see modest gains.

Limited to markets with exposure to U.S. consumer credit trends.

Counterpoint

Credit quality risks and rising competition could weigh on margins.

Key entities

  • Goldman Sachs

    Raised price target to $115.

  • Wolfe Research

    Upgraded to Outperform with $90 target.

Related articles

$AFRMMed

Affirm (AFRM) Stock Surges 5% on Transformer AI Model Launch for Credit Decisions

Affirm (AFRM) stock rose 5.5% premarket after launching an AI model for instant loan approvals, improving transaction completion rates by 3.4%. The system uses 14 years of proprietary data. Chief Accounting Officer Siphelele Jiyane sold $1.95M in shares. Analysts have a 'Moderate Buy' rating with a $98.78 price target, above the current $71.58. Q2 earnings beat estimates with $4.62 EPS and $1.07B revenue.

$AFRMMed

Affirm stock surges on new AI model for loan approvals

Affirm Holdings Inc (AFRM) shares rose 5.5% premarket after launching an AI model for real-time loan approvals. The model, live in the U.S., uses machine learning to analyze credit history, approving more loans with better performance. According to the company, it increased completed purchases by 3.4% compared to a control group. The technology aims to responsibly expand credit access without compromising repayment rates.

$AFRMMedAI 8/10

Goldman Sachs Is Bullish. Here Are 3 Reasons AFRM Stock Could Climb 69%.

Goldman Sachs and other firms raised their price targets for Affirm (AFRM), with a mean target of $99.48 and a high of $124. The company reported strong Q4 results, with interest income up 30% YOY and net income reaching $1.6 billion. Growth was driven by the Affirm Card, which saw active cardholders double and GMV surge 124%. The company also has significant growth potential in expanding its merchant network and new markets.